12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights 6 hours ago
Movers
Gainers Curis (NASDAQ:CRIS) stock increased by 25.6% to $0.83 during Tuesday's regular session. The company's market cap stands at $1.6 million. Pasithea Therapeutics (NASDAQ:KTTA) shares increased by 22.28%
Gainers
- Curis (NASDAQ:CRIS) stock increased by 25.6% to $0.83 during Tuesday's regular session. The company's market cap stands at $1.6 million.
- Pasithea Therapeutics (NASDAQ:KTTA) shares increased by 22.28% to $0.45. The market value of their outstanding shares is at $12.2 million.
- LENZ Therapeutics (NASDAQ:LENZ) shares increased by 20.98% to $3.69. The market value of their outstanding shares is at $95.8 million. As per the press release, Q3 earnings came out 4 days ago.
- Aurora Cannabis (NASDAQ:ACB) shares increased by 19.66% to $5.05. The market value of their outstanding shares is at $261.3 million.
- Neumora Therapeutics (NASDAQ:NMRA) shares rose 18.44% to $0.59. The company's market cap stands at $93.1 million.
- BioVie (NASDAQ:BIVI) shares moved upwards by 18.24% to $1.62. The company's market cap stands at $11.8 million.
Losers
- Jaguar Health (NASDAQ:JAGX) shares declined by 38.3% to $0.55 during Tuesday's regular session. The market value of their outstanding shares is at $2.0 million.
- Supernus Pharmaceuticals (NASDAQ:SUPN) shares decreased by 27.87% to $30.24. The company's, Q3 earnings came out 3 days ago.
- Cerenome (NASDAQ:CNSY) shares decreased by 27.78% to $1.24. The company's market cap stands at $12.9 million.
- Baird Medical Investment (NASDAQ:BDMD) shares declined by 27.32% to $0.1. The company's market cap stands at $4.4 million.
- Karyopharm Therapeutics (NASDAQ:KPTI) stock fell 24.47% to $0.08. The company's market cap stands at $2.5 million.
- Stevanato Group (NYSE:STVN) shares fell 24.02% to $15.0. The market value of their outstanding shares is at $5.3 billion. The company's, Q3 earnings came out today. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
